Literature DB >> 10544129

HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells.

P J Duerksen-Hughes1, J Yang, S B Schwartz.   

Abstract

The interaction between hosts and the viruses that infect them is a dynamic one, and a growing literature documents the fact that many viruses have developed mechanisms designed to avoid elimination by the host immune system. One of the immune strategies used by the host and targeted by virus proteins is apoptosis triggered by the cytokine tumor necrosis factor (TNF). Mouse fibroblast LM cells are spontaneously sensitive to TNF. When the wild-type E6 protein from the human papillomavirus type 16 (HPV 16) was expressed in LM cells, the cells became resistant to TNF. This resistance was examined by several means, including cell morphology, the dose- and time-independent response to TNF in a cell death ELISA, trypan blue exclusion, and cell proliferation. The level of p53 did not rise in TNF-treated cells prior to apoptosis, suggesting a p53-independent mechanism. Significant, though not complete, resistance to TNF was also observed following transfection of a plasmid expressing a mutant E6 protein, which is unable to mediate rapid degradation of the p53 tumor suppressor. These results indicate that the HPV 16 E6 protein can protect LM cells from TNF-triggered apoptosis and likely does so by a mechanism other than mediation of p53 degradation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544129     DOI: 10.1006/viro.1999.9977

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.

Authors:  John M Routes; Kristin Morris; Misoo C Ellison; Sharon Ryan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.

Authors:  Mei Xu; Rachel A Katzenellenbogen; Carla Grandori; Denise A Galloway
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

4.  Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner.

Authors:  Michael A James; John H Lee; Aloysius J Klingelhutz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 5.  Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.

Authors:  T O Garnett; P J Duerksen-Hughes
Journal:  Arch Virol       Date:  2006-07-27       Impact factor: 2.574

Review 6.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 7.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

8.  Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis.

Authors:  Maria Filippova; Valery A Filippov; Mercy Kagoda; Theodore Garnett; Nadya Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

Review 9.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

10.  Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.

Authors:  Devan Prabhavathy; Chandrasekaran Karthik Subramanian; Devarajan Karunagaran
Journal:  Biosci Rep       Date:  2015-02-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.